| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.3M | -28.6% | -57.2% |
| Cost of Revenue | $5.7M | -57.4% | -73.0% |
| Gross Profit | $5.6M | +130.5% | +6.7% |
| R&D Expense | $519K | -6.8% | -35.4% |
| SG&A Expense | $6.2M | +51.4% | -0.2% |
| Operating Income | -$2.4M | +49.3% | +62.7% |
| Pre-tax Income | $5.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $13.3M | +2.4% | -48.1% |
| Current Assets | $26.2M | +27.1% | -37.2% |
| Total Assets | $121.1M | +174.7% | +19.8% |
| Current Liabilities | $40.3M | -16.5% | -31.0% |
| Total Liabilities | $42.4M | -14.6% | -30.1% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.3M | — | — |
| Capital Expenditures | $77K | — | — |
| Investing Cash Flow | -$61.8M | — | — |
| Financing Cash Flow | $74.0M | — | — |
| Free Cash Flow | -$17.3M | — | — |
| +198.5% |
| +179.7% |
| Net Income | -$808K | +73.2% | +85.3% |
| EPS (Basic) | -$0.01 | +87.5% | +94.4% |
| EPS (Diluted) | -$0.01 | +87.5% | +94.4% |
| $78.7M |
| +1520.8% |
| +94.5% |